First Time Loading...

Science 37 Holdings Inc
NASDAQ:SNCE

Watchlist Manager
Science 37 Holdings Inc Logo
Science 37 Holdings Inc
NASDAQ:SNCE
Watchlist
Price: 5.75 USD Market Closed
Updated: May 26, 2024
Section:
 

Wall Street
Price Targets

SNCE Price Targets Summary
Science 37 Holdings Inc

Wall Street analysts forecast SNCE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNCE is 13.83 USD .

SNCE Lowest Forecast
Wall Street Target
Not Available
SNCE Average Forecast
Wall Street Target
13.83 USD
141% Upside
SNCE Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
13.83 USD
141% Upside
Highest
Price Target
Not Available
Science 37 Holdings Inc Competitors:
Price Targets
BIOT
Biotage AB
18% Upside
STVN
Stevanato Group SpA
48% Upside
CRL
Charles River Laboratories International Inc
23% Upside
S
SLV
Selvita SA
4% Upside
BIOT
Biotage AB
18% Upside
STVN
Stevanato Group SpA
48% Upside
CRL
Charles River Laboratories International Inc
23% Upside
S
SLV
Selvita SA
4% Upside
M
038290
Macrogen Inc
78% Upside
M
300463
Maccura Biotechnology Co Ltd
45% Upside
LONN
Lonza Group AG
12% Upside
MXCT
MaxCyte Inc
101% Upside

Revenue
Forecast

Revenue Estimate
Science 37 Holdings Inc

For the last 1 year the compound annual growth rate for Science 37 Holdings Inc's revenue is 18%. The projected CAGR for the next 4 years is 11%.

18%
Past Growth
11%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Science 37 Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Science 37 Holdings Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
SNCE intrinsic value, competitors valuation, and company profile.
DCF Valuation
SNCE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SNCE stock valuation using valuation multiples.
Wall Street Estimates
SNCE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SNCE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNCE's stock price target?
Price Target
13.83 USD

According to Wall Street analysts, the average 1-year price target for SNCE is 13.83 USD .

What is Science 37 Holdings Inc's Revenue forecast?
Projected CAGR
11%

For the last 1 year the compound annual growth rate for Science 37 Holdings Inc's revenue is 18%. The projected CAGR for the next 4 years is 11%.

ALPHA SPREAD
Join more than 140,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.